TrialJAMA internal medicine2017

Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.

Nicholas J Cowley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.